0001127602-22-003243.txt : 20220203
0001127602-22-003243.hdr.sgml : 20220203
20220203182551
ACCESSION NUMBER: 0001127602-22-003243
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fong Ivan K
CENTRAL INDEX KEY: 0001342238
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36820
FILM NUMBER: 22590118
MAIL ADDRESS:
STREET 1: 3M CENTER
CITY: ST. PAUL
STATE: MN
ZIP: 55144-1000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medtronic plc
CENTRAL INDEX KEY: 0001613103
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FISCAL YEAR END: 0429
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 01135314381700
MAIL ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Ltd
DATE OF NAME CHANGE: 20150112
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Holdings Ltd
DATE OF NAME CHANGE: 20140711
FORMER COMPANY:
FORMER CONFORMED NAME: Kalani I Ltd
DATE OF NAME CHANGE: 20140709
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-01
0001613103
Medtronic plc
MDT
0001342238
Fong Ivan K
710 MEDTRONIC PARKWAY LC300
MINNEAPOLIS
MN
55432
1
EVP GENERAL COUNSEL & SECR
Ordinary Shares
2022-02-01
4
A
0
6237
0
A
6237
D
Ordinary Shares
2022-02-01
4
A
0
24134
0
A
30371
D
Stock Option (Right to Buy)
103.59
2022-02-01
4
A
0
50476
103.59
A
2022-08-02
2031-08-02
Ordinary Shares
50476
50476
D
Performance Share Units
2022-02-01
4
A
0
15591
0
A
Performance Share Units
15591
15591
D
Stock Option (Right to Buy)
103.59
2022-02-01
4
A
0
145852
103.59
A
2023-02-01
2032-02-01
Ordinary Shares
145852
145852
D
Performance Share Units
2022-02-01
4
A
0
21238
0
A
Performance Share Units
21238
21238
D
The restrictions on these restricted stock units shall lapse 100% on August 2, 2024.
The restrictions on these restricted stock units shall vest 50% on December 10, 2022, 25% on December 10, 2023 and 25% on December 10, 2024.
These options become exercisable at the rate of 25% of the shares granted per year beginning on the date noted.
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,591 shares will be issued. The actual number of shares to be issued could range from a low of 3,118 at minimum performance to a high of 31,182 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Vests on August 2, 2024.
These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,238 shares will be issued. The actual number of shares to be issued could range from a low of 4,248 at minimum performance to a high of 42,476 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
/s/ Thomas L. Osteraas, attorney-in-fact
2022-02-03